Concepedia

Publication | Closed Access

Characteristics of Agranulocytosis as an Adverse Effect of Antithyroid Drugs in the Second or Later Course of Treatment

DOI

42

Citations

14

References

2013

Year

Sakiko Kobayashi, Jaeduk Yoshimura Noh, Koji Mukasa, Yo Kunii, Natsuko Watanabe, Masako Matsumoto, Hidemi Ohye, Miho Suzuki, Ai Yoshihara, Kenji Iwaku,
Thyroid

Abstract

When ATD treatment is resumed, patient follow-up is essential in order to monitor for the development of agranulocytosis.

References

YearCitations

Page 1